InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: quandongboy post# 23121

Thursday, 10/01/2009 1:41:25 PM

Thursday, October 01, 2009 1:41:25 PM

Post# of 30387
QD stated: "In fact, large companies like Abbott don't innovate. They sit back and wait for small companies to do the basic science and take an idea far enough towards commercialization that they (i.e., the large companies) can simply step in and license it. IMO that is what the large companies are doing. They are waiting for biocurex to provide enough hard data to satisfy them it will work."

REALLY? So when Abbott licensed RECAF way back in 2005, Moro had done no work on it? Moro showed them that it worked. In November 2004, he released a PR stating that RECAF had 90$ sensitivity and No false positives.

I think Moro did work on RECAF and Abbott attempted to validate that work and the results produced in May of 2006 did not come close to duplicating the results Moro had published in 2004.

If anyone still thinks that Abbott is working on RECAF or working with anyone else on RECAF, they have not done their homework. Abbott has not even paid the feasibility milestone.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.